Brief: ProQR Announces CTA Submission For Phase 1 Study Of AX-0810 Targeting NTCP
26/06/2025 22:44
June 26 (Reuters) - ProQR Therapeutics NV PRQR.O: PROQR ANNOUNCES CTA SUBMISSION FOR PHASE 1 STUDY OF AX-0810 TARGETING NTCP Source text: ID:nGNX1ZZl77 Further company coverage: PRQR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ProQR Therapeutics NV
See all newsProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary
ProQR Q2 revenue more than doubles
Brief: ProQR Therapeutics Q2 EPS EUR -0.08
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview